GERM vs. JDOC
GERM (Amplify Treatments, Testing and Advancements ETF) and JDOC (Jpmorgan Healthcare Leaders ETF) are both Health & Biotech Equities funds. GERM is passively managed, while JDOC is actively managed. Over the past year, GERM returned 0.00% vs 17.29% for JDOC. GERM charges 0.68%/yr vs 0.65%/yr for JDOC.
Performance
GERM vs. JDOC - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
JDOC
- 1D
- 1.11%
- 1M
- 2.00%
- YTD
- -0.08%
- 6M
- -0.49%
- 1Y
- 17.29%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM vs. JDOC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
JDOC Jpmorgan Healthcare Leaders ETF | -0.08% | 15.36% | -13.95% |
GERM vs. JDOC - Sectors Allocation Comparison
Sectors
GERM
JDOC
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
GERM
JDOC
Financial Services
GERM
JDOC
-
Basic Materials
GERM
-
JDOC
-
Communication Services
GERM
-
JDOC
-
Consumer Cyclical
GERM
-
JDOC
-
Consumer Defensive
GERM
-
JDOC
-
Energy
GERM
-
JDOC
-
Industrials
GERM
-
JDOC
-
Real Estate
GERM
-
JDOC
-
Technology
GERM
-
JDOC
-
Utilities
GERM
-
JDOC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. JDOC — Risk / Return Rank
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
JDOC
GERM vs. JDOC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Jpmorgan Healthcare Leaders ETF (JDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERM | JDOC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.22 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 1.79 | — |
| Martin ratioReturn relative to average drawdown | — | 4.54 | — |
Loading charts...
Drawdowns
GERM vs. JDOC - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum JDOC drawdown of -20.87%. Use the drawdown chart below to compare losses from any high point for GERM and JDOC.
Loading charts...
Drawdown Indicators
| GERM | JDOC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -20.87% | +20.87% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -9.68% | +9.68% |
Current DrawdownCurrent decline from peak | 0.00% | -3.20% | +3.20% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -6.93% | +6.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 3.81% | -3.81% |
Volatility
GERM vs. JDOC - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Jpmorgan Healthcare Leaders ETF (JDOC) has a volatility of 5.26%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than JDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | JDOC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 5.26% | -5.26% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 10.56% | -10.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 14.35% | -14.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 14.52% | -14.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 14.52% | -14.52% |
GERM vs. JDOC - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than JDOC's 0.65% expense ratio.
Dividends
GERM vs. JDOC - Dividend Comparison
GERM has not paid dividends to shareholders, while JDOC's dividend yield for the trailing twelve months is around 0.89%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% |
JDOC Jpmorgan Healthcare Leaders ETF | 0.89% | 0.89% | 5.57% | 0.15% |
Frequently Asked Questions
JDOC has higher volatility (5.26%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs JDOC's -20.87%.
On 1-year performance, JDOC leads with 17.29% vs 0.00% for GERM. On fees, JDOC is cheaper at 0.65% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, JDOC has performed better with a 17.29% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
JDOC is cheaper with a 0.65% expense ratio, compared with 0.68% for GERM.
JDOC has the higher dividend yield at 0.89%, compared with 0.00% for GERM.
They also come from different issuers: Amplify and JPMorgan. Their fees differ too: 0.68% for GERM and 0.65% for JDOC.
Find the right allocation for GERM and JDOC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer